Literature DB >> 10426155

Fulminant form of acute disseminated encephalomyelitis: successful treatment with hypothermia.

T Takata1, M Hirakawa, M Sakurai, I Kanazawa.   

Abstract

We described herein a case of the fulminant form of acute disseminated encephalomyelitis (ADEM) that developed after mycoplasma pneumonia. A 28-year-old man who presented with fever, headache, and writing difficulty was admitted to our hospital in August 1997. He developed hernia on the 3rd hospital day. Surgical decompression and intravenous prednisolone failed to halt his progressive deterioration. We introduced systemic hypothermia and he has shown marked recovery; despite having Broca's type aphasia, he could comprehend spoken language and communicate with others by gesture. Head MRI demonstrated diffuse high signals over the white matter on fluid attenuated inversion recovery (FLAIR) images, which suggested extensive demyelination. The clinical course, imaging studies and presence of polymorphonuclear dominant leucocytosis in the blood and CSF in the patient are somewhat similar to findings in acute hemorrhagic leukoencephalitis, however, the result of a brain biopsy was inconclusive. The fulminant form of ADEM is usually fatal. Treatments such as corticosteroids, intravenous immunoglobulin, and surgical decompression have been performed to improve the prognosis. Our case results indicate that hypothermia, which suppresses both brain edema and immune response, may be included in the repertoire of treatment for the fulminant form of ADEM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426155     DOI: 10.1016/s0022-510x(99)00089-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Fatal acute disseminated encephalomyelitis associated with cytomegalovirus infection.

Authors:  Reut Zaguri; Ilan Shelef; Gal Ifergan; Yaniv Almog
Journal:  BMJ Case Rep       Date:  2009-03-17

Review 3.  Decompressive craniectomy for acute disseminated encephalomyelitis.

Authors:  A I Ahmed; C A Eynon; L Kinton; J A R Nicoll; A Belli
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

Review 4.  Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. Part 1: Indications and evidence.

Authors:  Kees H Polderman
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

5.  Fulminant demyelinating diseases.

Authors:  Megan R Rahmlow; Orhun Kantarci
Journal:  Neurohospitalist       Date:  2013-04

6.  Treatment of acute disseminated encephalomyelitis.

Authors:  Daniela Pohl; Silvia Tenembaum
Journal:  Curr Treat Options Neurol       Date:  2012-06       Impact factor: 3.972

7.  Acute disseminated encephalomyelitis: Treatment guidelines.

Authors:  M Alexander; J M K Murthy
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

8.  Refractory Fulminant Acute Disseminated Encephalomyelitis (ADEM) in an Adult.

Authors:  Federico Rodríguez-Porcel; Alejandro Hornik; Jordan Rosenblum; Ewa Borys; José Biller
Journal:  Front Neurol       Date:  2014-12-23       Impact factor: 4.003

9.  Use of Cyclophosphamide in a Child With Fulminant Acute Disseminated Encephalomyelitis.

Authors:  Hana Ayed; Mohammed W Chaudhary; Raidah AlBaradie; Ali Mir
Journal:  Child Neurol Open       Date:  2018-03-11

Review 10.  Postinfectious encephalomyelitis.

Authors:  Dean M Wingerchuk
Journal:  Curr Neurol Neurosci Rep       Date:  2003-05       Impact factor: 6.030

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.